Abstract:OBJECTIVE To observe the dynamic changes of plasma inflammatory cytokine interleukin-1 beta (IL-1 beta) in patients with acute myocardiac infarction (AMI) before and after recanalization of the infarct related artery (IRA) and to observe the effect of recombinant human IL-1 receptor antagonist (rhIL-1ra) on the postischemic reperfused myocardium in experimental rabbits. METHODS (1) ELISA was used to measure the plasma IL-1 beta of 22 AMI patients, 20 males and 2 females, aged 64 +/- 12, before emergency percutaneous coronary intervention (PCI), and 12 hours and 24 hours after-intervention, and measure the plasma IL-1 beta of 8 healthy controls, 6 males and 2 females, aged 56 +/- 9. (2) Forty rabbits underwent ligation of the left circumflex branch of coronary artery (LCX) for 50 minutes and reperfusion for 4 hours after the ligatures were untied. The rabbits were randomly divided into 4 groups of 10 rabbits to be injected into the left ventricle immediately before the reperfusion with rhIL-1ra 10 mg/kg (group A), 20 mg/kg (group B), or 40 mg/kg (group C), and normal saline (control group) respectively. After reperfusion of 4 hours, the LCX was re-ligated. Evans blue was injected into the left ventricle. 15% KCl was injected intravenously to kill the rabbits. Their hearts were taken out to weigh the non-ischemic, ischemic, and necrotic cardiac muscles so as to calculate the infarct size. The myoperoxidase (MPO) activity was measured by colorimetry. Sections of myocardium were made. The number of apoptotic cardiomyocytes was evaluated by TUNEL method. The apoptotic rate of cardiomyocyte was measured by annexin V method. The DNA expression of myocardium was detected by DNA laddering method. The expressions of Bcl-2 and Bax apoptosis genes were assessed. RESULTS (1) The average plasma IL-1 beta level of the 22 AMI patients before emergency PCI was significantly higher than that of the controls (28 pg/ml +/- 9 pg/ml vs. 20 pg/ml +/- 11 pg/ml, P < 0.05), and became the highest 12 hours after the intervention (86 pg/ml +/- 14 pg/ml), and the high level lasted to 24 hours after emergency PCI. (2) In the ischemia-reperfusion rabbit model, the infarct size was 47% +/- 7% in the group A, 34% +/- 8% in the group B, 31% +/- 6% in the group C, and 61% +/- 11% in the control group (P < 0.05, 0.01, and 0.01 respectively). The activity of myocardial MPO was 16.6 +/- 3.6 min(-1).g.w.w(-1) in the group A, 10.9 min(-1).g.w.w(-1) +/- 1.9 min(-1).g.w.w(-1) in the group B, 7.8 min(-1).g.w.w(-1) +/- 2.2 min(-1).g.w.w(-1) in the group C, and 20.5 min(-1).g.w.w(-1) +/- 4.5 min(-1).g.w.w(-1) in the control group (P < 0.05, 0.01, and 0.01 respectively). The cardiomyocyte apoptosis evaluated by TUNEL was 38.3 n/HP +/- 7.4 n/HP in the group A, 25.6 n/HP +/- 6.8 n/HP in the group B, 12.2 n/HP +/- 3.3 n/HP in the group C, and 44.4 n/HP +/- 9.5 n/HP in the control group (P < 0.05, and P < 0.01 respectively in comparison between the group B and the control group and between the group C and the control group). The apoptotic rate by annexin V method was 11.6% +/- 2.7% in the group A; 7.7% +/- 2.4% in the group B, 4.7% +/- 1.4% in the group C, and 15.6% +/- 3.5% in the control group (P < 0.05, 0.01, and 0.01 respectively). DNA electrophoresis showed scaling ladder pattern only in the control group. The fluorescent density of the apoptosis gene Bax in myocardium was 24.9 +/- 8.2 in the group A; 15.5 +/- 3.4 in the group B, 10.6 +/- 2.5 in the group C, and 33.3 +/- 9.4 in the control group (P = 0.0298, 0091, and 0052 respectively) and no significant difference in the expression of Bcl-2 was shown among the 4 groups. Myocardial MPO was correlated with cardiomyocyte apoptosis (r = 0.86 by TUNEL, P < 0.01; r = 0.75 by Annexin V method, P < 0.05). CONCLUSION Inflammatory cytokine IL-1 beta is involved in myocardial ischemia-reperfusion injury. With potential therapeutic value in prevention and treatment of ischemia-reperfusion injury to myocardium, rhIL-1ra may reduce myocardial ischemia-reperfusion injury by suppression of cardiomyocytes apoptosis mediated by IL-als; 0.86 by TUNEL, P < 0.01; r = 0.75 by Annexin V method, P < 0.05). CONCLUSION Inflammatory cytokine IL-1 beta is involved in myocardial ischemia-reperfusion injury. With potential therapeutic value in prevention and treatment of ischemia-reperfusion injury to myocardium, rhIL-1ra may reduce myocardial ischemia-reperfusion injury by suppression of cardiomyocytes apoptosis mediated by IL-1.

Relationship Between Levels of Serum IL-1β and IL-1Ra and Restenosis in Patients with Intra and Extra-Cranial Arteriostenosis after Stent-Assisted Angioplasty

The Change and Clinical Significance of Serum Tumor Necrosis Factor-Α、interleukin-6 and Interleukin-8 after Cutting Balloon Angioplasty and Stent Implantation

To Explore the Relationship between Clinical Serum Markers and Intracoronary in-stent Restenosis

Relationship Between Plasma Level of IL-18,ox-LDL and the Development of Emergency Percutaneous Coronary Intervention

The Clinical Significance of Monitoring for Serum IL-1b 、Il-1Ra and IL-1Ra/IL-b Ratio in Patients with Coronary Heart Disease

Clinical Significance of Endothelin-1 And C Reaction Protein in Restenosis After the Intervention of Lower Extremity Arteriosclerosis Obliterans

Effect of Serum IL-6 Levels on the Progression of Non-Target Lesions in Patients after Coronary Stenting

Time Course of Inflammatory Response after Renal Artery Stenting in Patients with Atherosclerotic Renal Stenosis.

The Relationship Between the Levels of Plasma Homocysteine and the Restenosis of Intracranial or Extracranial Artery Before and after Stent Implantation

Elevated Level of Mir-17 along with Decreased Levels of TIMP-1 and IL-6 in Plasma Associated with the Risk of In-Stent Restenosis

Higher Serum Cystatin C and Matrix Metalloproteinase 9 Levels Effectively Predict In-Stent Restenosis after Stent Implantation for Intracranial and Extracranial Arterial Stenosis

Effect of the Plasma Interleukin- 1β Level on Prognosis of Patients with ST-segment Elevation Acute Myocardial Infarction

Correlation between the dynanic changes of serum high-sensitivity Creactive protein and restenosis after internal carotid artery stenting

Correlation Between the Dynamic Changes of Senlm High-Sensitivity Creactive Protein and Restenosis after Internal Carotid Anery Stenting

[The Protective Effect of Interleukin-1 Receptor Antagonist on Postischemic Reperfused Myocardium and Its Possible Mechanism].

Relationship Between Interleukin-18 Levels and Characterization of Atherosclerotic Plaque and Percutaneous Coronary Intervention

Relationship among level of serum glutaminyl transferase, inflammatory response and angiogenesis in patients with stent restenosis

Six-month Results of Stenting of the Femoropopliteal Artery and Predictive Value of Interleukin-6: Comparison with High-Sensitivity C-reactive Protein.

Correlations of serum high sensitivity C reactive protein and serum amyloid A concentrations after PCI with in-stent restenosis

TLR3 and TLR4 As Potential Clinical Biomarkers for In-Stent Restenosis in Drug-Eluting Stents Patients

Serum levels of tumor necrosis factor-α and interleukin-6 after SafeCutTM angioplasty and stent implantation and their clinical significance